Remission of type 2 diabetes: is bariatric surgery ready for prime time?

Endocrine

Volumn 48, Issue 2, 2015, Pages 417-421

  Esposito, Katherine ^a   Maiorino, Maria Ida ^a   Petrizzo, Michela ^b   Bellastella, Giuseppe ^a   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Centro Direzionale Is   (Italy)

Author keywords

Bariatric surgery; Intensive lifestyle intervention; Remission; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ARTICLE; BARIATRIC SURGERY; CLINICAL EFFECTIVENESS; CLINICAL STUDY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DRUG THERAPY; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTRIC BANDING; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL APPROACH; SURGICAL TECHNIQUE; WEIGHT REDUCTION; DIABETES MELLITUS, TYPE 2; PROCEDURES; RISK REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; REMISSION INDUCTION; RISK REDUCTION BEHAVIOR;

EID: 84924291816     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0463-z     Document Type: Article

References (25)

1. J.B. Buse, S. Caprio, W.T. Cefalu, A. Ceriello, S. Del Prato, S.E. Inzucchi, S. McLaughlin, G.L. Phillips 2nd, R.P. Robertson, F. Rubino, R. Kahn, M.S. Kirkman, How do we define cure of diabetes? Diabetes Care 32, 2133–2135 (2009)
2. A.P. Courcoulas, S.Z. Yanoski, D. Bonds, T.L. Eggerman, M. Horlick, M.A. Staten, D.E. Arterburn, Long-term outcomes of bariatric surgery. A National Institutes of Health Symposium. JAMA Surg. doi:10.1001/jamasurg.2014.2440 (2014)
3. V.L. Gloy, M. Briel, D.L. Bhatt, S.R. Kashyap, P.R. Schauer, G. Mingrone, H.C. Bucher, A.J. Nordmann, Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347, f5934 (2013)
4. M.P. Hage, B. Safadi, I. Salti, M. Nasrallah, Role of gut-related peptides and other hormones in the amelioration of type 2 diabetes after Roux-en-Y gastric bypass surgery. ISRN Endocrinol. 2012, 504756 (2012)
5. A.P. Shukla, S.M. Ahn, R.T. Patel, M.W. Rosenbaum, F. Rubino, Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine 40, 151–161 (2011)
6. P.R. Schauer, S. Ikramuddin, W. Gourash, R. Ramanathan, J. Luketich, Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Annal. Surg. 232, 515–529 (2000)
7. B. Laferrère, Do we really know why diabetes remits after gastric bypass surgery? Endocrine 40, 162–167 (2011)
8. G. Mingrone, S. Panunzi, A. De Gaetano, C. Guidone, A. Iaconelli, L. Leccesi, G. Nanni, A. Pomp, M. Castagneto, G. Ghirlanda, F. Rubino, Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 366, 1577–1585 (2012)
9. P.R. Schauer, S.R. Kashyap, K. Wolski, S.A. Brethauer, J.P. Kirwan, C.E. Pothier, S. Thomas, B. Abood, S.E. Nissen, Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med. 366, 1567–1576 (2012)
10. Z. Liang, Q. Wu, B. Chen, P. Yu, H. Zhao, X. Ouyang, Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res. Clin. Prac. 101, 50–56 (2013)
11. J.B. Dixon, P.E. O’Brien, J. Playfair, L. Chapman, L.M. Schachter, S. Skinner, J. Proietto, M. Bailey, M. Anderson, Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299, 316–323 (2008)
12. M. Maggard-Gibbons, M. Maglione, M. Livhits, Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes. A systematic review. JAMA 309, 2250–2261 (2013)
13. N. Puzziferri, T.B. Roshek III, H.G. Mayo, R. Gallagher, S.H. Belle, E.H. Livingston, Long-term follow-up after bariatric surgery. A systematic review. JAMA 312, 934–942 (2014)
14. T.D. Adams, L.E. Davidson, S.E. Litwin, R.L. Kolotkin, M.J. LaMonte, R.C. Pendleton, M.B. Strong, R. Vinik, N.A. Wanner, P.N. Hopkins, R.E. Gress, J.M. Walker, T.V. Cloward, R.T. Nuttall, A. Hammoud, J.L. Greenwood, R.D. Crosby, R. McKinlay, S.C. Simper, S.C. Smith, S.C. Hunt, Health benefits of gastric bypass surgery after 6 years. JAMA 308, 1122–1131 (2012)
15. A.P. Courcoulas, N.J. Christian, S.H. Belle, P.D. Berk, D.R. Flum, L. Garcia, M. Horlick, M.A. Kalarchian, W.C. King, J.E. Mitchell, E.J. Patterson, J.R. Pender, A. Pomp, W.J. Pories, R.C. Thirlby, S.Z. Yanovski, B.M. Wolfe, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310, 2416–2425 (2013)
16. R. Caiazzo, L. Arnalsteen, M. Pigeyre, G. Dezfoulian, H. Verkindt, J. Kirkby-Bott, P. Mathurin, P. Fontaine, M. Romon, F. Pattou, Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br. J. Surg. 97, 884–891 (2010)
17. E. Phillips, J. Ponce, S.A. Cunneen, S. Bhoyrul, E. Gomez, S. Ikramuddin, M. Jacobs, M. Kipnes, L. Martin, R.T. Marema, J. Pilcher, R. Rosenthal, R. Rubenstein, J. Teixeira, T. Trus, N. Zundel, Safety and effectiveness of Realize adjustable gastric band: 3-year prospective study in the United States. Surg. Obes. Relat. Dis. 5, 588–597 (2009)
18. S. Sultan, D. Gupta, M. Parikh, H. Youn, M. Kurian, G. Fielding, C. Ren-Fielding, Five-year outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding. Surg. Obes. Relat. Dis. 6, 373–376 (2010)
19. S. Ikramuddin, J. Korner, W.-J. Lee, J.E. Connett, W.B. Inabnet, C.J. Billington, A.J. Thomas, D.B. Leslie, K. Chong, R.W. Jeffery, L. Ahmed, A. Vella, L.M. Chuang, M. Bessler, M.G. Sarr, J.M. Swain, P. Laqua, M.D. Jensen, J.P. Bantle, Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The Diabetes Surgery Study randomized clinical trial. JAMA 309, 2240–2249 (2013)
20. P.R. Schauer, D.L. Bhatt, J.P. Kirwan, K. Wolski, S.A. Brethauer, S.D. Navaneethan, A. Aminian, C.E. Pothier, E.S. Kim, S.E. Nissen, S.R. Kashyap, STAMPEDE Investigators, Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N. Engl. J. Med. 370, 2002–2013 (2014)
21. E.W. Gregg, H. Chen, L.E. Wagenknecht, J.M. Clark, L.M. Delahanty, J. Bantle, H.J. Pownall, K.C. Johnson, M.M. Safford, A.E. Kitabchi, F.X. Pi-Sunyer, R.R. Wing, A.G. Bertoni, Look AHEAD Research Group, Association of an intensive lifestyle intervention with remission of Type 2 diabetes. JAMA 308, 2489–2496 (2012)
22. K. Esposito, M.I. Maiorino, M. Petrizzo, G. Bellastella, D. Giugliano, The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care 37, 1824–1830 (2014)
23. E.S. Schellenberg, D.M. Dryden, B. Vandermeer, C. Ha, C. Korownyk, Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann. Intern. Med. 159, 543–551 (2013)
24. K. Esposito, P. Chiodini, M.I. Maiorino, G. Bellastella, D. Panagiotakos, D. Giugliano, Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine 47, 107–116 (2014)
25. K. Esposito, D. Giugliano, Healthy lifestyle for metabolic health: no more excuse! Endocrine 46, 176–178 (2014)